Skip to main content
Premium Trial:

Request an Annual Quote

Danish Array Firm Exiqon Jettisons Sales Staff, Shutters US Office

NEW YORK, May 31 - Danish microarray company Exiqonsaid today it has cut its staff and closed its US sales office.


Though it was not immediately clear how many people lost their jobs, the cuts come mainly from sales and marketing with a smaller number coming from the R&D side, according to Lars Kongsbak, Exiqon's vice president for business development, science, and technology.


The Vedbaek-based maker of microarrays, microplates, and locked nucleic acids is now pursuing "an M&A strategy," said Kongsbak. "Instead of trying to sell our products ourselves we are now looking for partners who will take that on."


Kongsback said the cuts and shift in strategy were motivated principally by the fact that the company' could not see an IPO in the near future, leaving its venture capital backers with no viable exit strategy.


An in-depth version of this article can be read next week on BioArray News.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.